Scheme 1.
Schematic actions of MMAF delivery systems with active targeting ability and ROS-responsiveness. The nanoparticles are efficiently internalized into the tumor cells. Intracellular ROS facilitates the disruption of the nanoparticles, which release MMAF to exert the anticancer effects by inhibiting tubulin polymerization.